Dhampur Bio Organics Limited (NSE: DBOL)
India
· Delayed Price · Currency is INR 159.75
+3.56 (2.28%)
Sep 27, 2024, 3:29 PM IST
Dhampur Bio Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 17,481 | 18,644 | 24,075 | 15,641 | - |
| Revenue Growth (YoY) | -29.94% | -22.56% | 53.93% | - | - |
| Cost of Revenue | 13,120 | 14,027 | 18,580 | 11,718 | - |
| Gross Profit | 4,362 | 4,617 | 5,495 | 3,923 | - |
| Selling, General & Admin | 990.5 | 1,005 | 1,109 | 750.5 | - |
| Other Operating Expenses | 2,035 | 2,184 | 2,221 | 1,261 | 0.24 |
| Operating Expenses | 3,528 | 3,684 | 3,735 | 2,324 | 0.24 |
| Operating Income | 833.7 | 933.5 | 1,760 | 1,599 | -0.24 |
| Interest Expense | -511.5 | -433.6 | -380.8 | -294.2 | - |
| Interest & Investment Income | 23.1 | 23.1 | 4.8 | 5.2 | - |
| Currency Exchange Gain (Loss) | 14.1 | 14.1 | -7.2 | -0.1 | - |
| Other Non Operating Income (Expenses) | -19.7 | -19.7 | -27.6 | -2.7 | - |
| EBT Excluding Unusual Items | 339.7 | 517.4 | 1,349 | 1,307 | -0.24 |
| Merger & Restructuring Charges | -0.4 | -0.4 | -2 | -30 | - |
| Gain (Loss) on Sale of Assets | 137.9 | 137.9 | 0.3 | 16.7 | - |
| Pretax Income | 477.2 | 654.9 | 1,348 | 1,294 | -0.24 |
| Income Tax Expense | 137.7 | 190 | 236.7 | 270.8 | - |
| Net Income | 339.5 | 464.9 | 1,111 | 1,023 | -0.24 |
| Net Income to Common | 339.5 | 464.9 | 1,111 | 1,023 | -0.24 |
| Net Income Growth | -70.61% | -58.15% | 8.57% | - | - |
| Shares Outstanding (Basic) | 65 | 66 | 66 | 66 | - |
| Shares Outstanding (Diluted) | 65 | 66 | 66 | 66 | - |
| Shares Change (YoY) | -2.27% | - | - | - | - |
| EPS (Basic) | 5.24 | 7.00 | 16.74 | 15.41 | - |
| EPS (Diluted) | 5.24 | 7.00 | 16.74 | 15.41 | - |
| EPS Growth | -69.92% | -58.15% | 8.57% | - | - |
| Free Cash Flow | - | -2,720 | 1,448 | -4,078 | -0.24 |
| Free Cash Flow Per Share | - | -40.97 | 21.81 | -61.43 | - |
| Dividend Per Share | - | 2.500 | 3.500 | - | - |
| Dividend Growth | - | -28.57% | - | - | - |
| Gross Margin | 24.95% | 24.76% | 22.82% | 25.08% | - |
| Operating Margin | 4.77% | 5.01% | 7.31% | 10.22% | - |
| Profit Margin | 1.94% | 2.49% | 4.61% | 6.54% | - |
| Free Cash Flow Margin | - | -14.59% | 6.01% | -26.08% | - |
| EBITDA | 1,309 | 1,389 | 2,133 | 1,889 | - |
| EBITDA Margin | 7.49% | 7.45% | 8.86% | 12.08% | - |
| D&A For EBITDA | 475.58 | 455.1 | 373.2 | 289.5 | - |
| EBIT | 833.7 | 933.5 | 1,760 | 1,599 | -0.24 |
| EBIT Margin | 4.77% | 5.01% | 7.31% | 10.22% | - |
| Effective Tax Rate | 28.86% | 29.01% | 17.56% | 20.93% | - |
| Revenue as Reported | 23,451 | 24,183 | 26,659 | 15,718 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.